SCHEMBL8369232

SCHEMBL8369232

CN(CCCCCO)C(=O)c1ccccc1-c1ccc(Cl)c(Cl)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
ALDH1A1 P00352 1/20 0.46
PDK2 Q15119 3/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
RORB Q92753 1/20 0.42
TACR1 P25103 3/20 0.41
CHRM1 P11229 1/20 0.41
GABRA1 P14867 1/20 0.39
GABRB2 P47870 1/20 0.39
PTGER1 P34995 1/20 0.39
PTGER3 P43115 1/20 0.39
PTGER2 P43116 1/20 0.39
SLC6A4 P31645 2/20 0.38
SLC6A3 Q01959 2/20 0.38
SLC6A2 P23975 1/20 0.38
EIF4E P06730 1/20 0.37
CDK4 P11802 1/20 0.36
CCND1 P24385 1/20 0.36
LTB4R2 Q9NPC1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8366286 0.99 MEN1 (0.47) MEN1KMT2AALDH1A1PDK2SMN1; SMN2
SCHEMBL8419210 0.85 TSHR (0.49) MEN1KMT2AALDH1A1SMN1; SMN2RORB
SCHEMBL8417383 0.85 MEN1 (0.42) MEN1KMT2AALDH1A1PDK2SMN1; SMN2
SCHEMBL8370044 0.84 MEN1 (0.40) MEN1KMT2AALDH1A1PDK2SMN1; SMN2
SCHEMBL8368909 0.82 MEN1 (0.41) MEN1KMT2AALDH1A1PDK2SMN1; SMN2
SCHEMBL8369030 0.82 MEN1 (0.47) MEN1KMT2AALDH1A1PDK2SMN1; SMN2
Hydrochloric Acid SCHEMBL8574952 0.77 TACR2 (0.48) MEN1KMT2A
SCHEMBL8417311 0.76 MEN1 (0.40) MEN1KMT2AALDH1A1RORBTACR1
SCHEMBL8574996 0.72 TACR2 (0.56) TACR1
SCHEMBL1515709 0.72 EIF4E (0.58) RORBCHRM1PTGER1PTGER3PTGER2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5942523-A NOVEL PIPERIDINE DERIVATIVES WHOSE SPECIFIC STRUCTURE INCLUDES AT POSITION 1 AN ALKYL CHAIN HAVING A 3,4-DICHLOROPHENYL GROUP ATTACHED; HIGH SELECTIVITY TO THE NK3 RECEPTOR; UNIT DOSAGE FORM; TREATING PSYCHIATRIC DISEASES SANOFI (FR) 1999-08-24 US disclosed